Financhill
Back

Supernus Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
44

SUPN
Supernus Pharmaceuticals

Last Price:
$36.88
Seasonality Move:
10.46%
Sell
49

NBY
NovaBay Pharmaceuticals

Last Price:
$0.61
Seasonality Move:
15.02%
Sell
44
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $36.92. The Score for SUPN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.62. The Score for NBY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $36.92
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.62
    The current trend is relatively stagnant and NBY is experiencing slight buying pressure.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 56.25 Buy
Chaikin Money Flow: 217233 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.91 - 37.07) Buy
Bollinger Bands (100): (32.53 - 36.49) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 56.07 Buy
Chaikin Money Flow: -8007 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.54 - 0.6) Buy
Bollinger Bands (100): (0.51 - 0.69) Buy

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.38 Buy
20-day SMA: 36.36 Buy
50-day SMA: 36.01 Buy
200-day SMA: 31.95 Buy
8-day EMA: 36.47 Buy
20-day EMA: 36.33 Buy
50-day EMA: 35.7 Buy
200-day EMA: 32.84 Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.58 Buy
20-day SMA: 0.56 Buy
50-day SMA: 0.63 Sell
200-day SMA: 1.71 Sell
8-day EMA: 0.59 Buy
20-day EMA: 0.58 Buy
50-day EMA: 0.63 Sell
200-day EMA: 4.39 Sell

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.96 per share, and an increase next year of $0.44 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):